ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.

Sara M Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.